These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9678717)

  • 1. The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).
    Peng B; Zhang M; Sun R; Lin YC; Chong SY; Lai H; Stein D; Raveche ES
    Leuk Res; 1998 Jun; 22(6):509-16. PubMed ID: 9678717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cultured malignant B-1 line serves as a model for Richter's syndrome.
    Peng B; Sherr DH; Mahboudi F; Hardin J; Wu YH; Sharer L; Raveché ES
    J Immunol; 1994 Aug; 153(4):1869-80. PubMed ID: 8046247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NZB mouse as a model for chronic lymphocytic leukemia.
    Phillips JA; Mehta K; Fernandez C; Raveché ES
    Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.
    Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T
    Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein.
    di Celle PF; Carbone A; Marchis D; Zhou D; Sozzani S; Zupo S; Pini M; Mantovani A; Foa R
    Blood; 1994 Jul; 84(1):220-8. PubMed ID: 7517209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle effects of IL-10 on malignant B-1 cells.
    Yen Chong S; Lin YC; Czarneski J; Zhang M; Coffman F; Kashanchi F; Raveche E
    Genes Immun; 2001 Aug; 2(5):239-47. PubMed ID: 11528515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
    DiLillo DJ; Weinberg JB; Yoshizaki A; Horikawa M; Bryant JM; Iwata Y; Matsushita T; Matta KM; Chen Y; Venturi GM; Russo G; Gockerman JP; Moore JO; Diehl LF; Volkheimer AD; Friedman DR; Lanasa MC; Hall RP; Tedder TF
    Leukemia; 2013 Jan; 27(1):170-82. PubMed ID: 22713648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
    Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
    J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.
    Ramachandra S; Metcalf RA; Fredrickson T; Marti GE; Raveche E
    J Clin Invest; 1996 Oct; 98(8):1788-93. PubMed ID: 8878429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model of chronic lymphocytic leukemia with Ritcher's transformation in severe combined immunodeficiency mice.
    Su YC; Wu WM; Wu MF; Chiang BL
    Exp Hematol; 2001 Oct; 29(10):1218-25. PubMed ID: 11602324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
    Levesque MC; Misukonis MA; O'Loughlin CW; Chen Y; Beasley BE; Wilson DL; Adams DJ; Silber R; Weinberg JB
    Leukemia; 2003 Feb; 17(2):442-50. PubMed ID: 12592345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin 10 in B lymphocytes of different origin.
    Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
    Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory role of T cells in a murine model of lymphoproliferative disease.
    Raveche E; Fernandes H; Ong H; Peng B
    Cell Immunol; 1998 Jul; 187(1):67-75. PubMed ID: 9682005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide.
    Peng B; Mehta NH; Fernandes H; Chou CC; Raveché E
    Leuk Res; 1995 Mar; 19(3):159-67. PubMed ID: 7535370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference of IL-10 in leukemic B-1 cells.
    McCarthy BA; Mansour A; Lin YC; Kotenko S; Raveche E
    Cancer Immun; 2004 Jul; 4():6. PubMed ID: 15270555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.
    Holler C; Piñón JD; Denk U; Heyder C; Hofbauer S; Greil R; Egle A
    Blood; 2009 Mar; 113(12):2791-4. PubMed ID: 19168795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models.
    Bertilaccio MT; Simonetti G; Dagklis A; Rocchi M; Rodriguez TV; Apollonio B; Mantovani A; Ponzoni M; Ghia P; Garlanda C; Caligaris-Cappio F; Muzio M
    Blood; 2011 Jul; 118(3):660-9. PubMed ID: 21652674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
    Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
    BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.